Literature DB >> 22118289

Aristolochic acid I metabolism in the isolated perfused rat kidney.

Horacio A Priestap1, M Cecilia Torres, Robert A Rieger, Kathleen G Dickman, Tomoko Freshwater, David R Taft, Manuel A Barbieri, Charles R Iden.   

Abstract

Aristolochic acids are natural nitro-compounds found globally in the plant genus Aristolochia that have been implicated in the severe illness in humans termed aristolochic acid nephropathy (AAN). Aristolochic acids undergo nitroreduction, among other metabolic reactions, and active intermediates arise that are carcinogenic. Previous experiments with rats showed that aristolochic acid I (AA-I), after oral administration or injection, is subjected to detoxication reactions to give aristolochic acid Ia, aristolactam Ia, aristolactam I, and their glucuronide and sulfate conjugates that can be found in urine and feces. Results obtained with whole rats do not clearly define the role of liver and kidney in such metabolic transformation. In this study, in order to determine the specific role of the kidney on the renal disposition of AA-I and to study the biotransformations suffered by AA-I in this organ, isolated kidneys of rats were perfused with AA-I. AA-I and metabolite concentrations were determined in perfusates and urine using HPLC procedures. The isolated perfused rat kidney model showed that AA-I distributes rapidly and extensively in kidney tissues by uptake from the peritubular capillaries and the tubules. It was also established that the kidney is able to metabolize AA-I into aristolochic acid Ia, aristolochic acid Ia O-sulfate, aristolactam Ia, aristolactam I, and aristolactam Ia O-glucuronide. Rapid demethylation and sulfation of AA-I in the kidney generate aristolochic acid Ia and its sulfate conjugate that are voided to the urine. Reduction reactions to give the aristolactam metabolites occur to a slower rate. Renal clearances showed that filtered AA-I is reabsorbed at the tubules, whereas the metabolites are secreted. The unconjugated metabolites produced in the renal tissues are transported to both urine and perfusate, whereas the conjugated metabolites are almost exclusively secreted to the urine.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22118289      PMCID: PMC3276251          DOI: 10.1021/tx200333g

Source DB:  PubMed          Journal:  Chem Res Toxicol        ISSN: 0893-228X            Impact factor:   3.739


  31 in total

1.  Renal excretion of clofarabine: assessment of dose-linearity and role of renal transport systems on drug excretion.

Authors:  Antoinette D Ajavon; Peter L Bonate; David R Taft
Journal:  Eur J Pharm Sci       Date:  2010-03-25       Impact factor: 4.384

2.  Endemic nephropathy: the case for chronic poisoning by aristolochia.

Authors:  Tjasa Hranjec; Anamarija Kovac; Jelena Kos; Wenyang Mao; John J Chen; Arthur P Grollman; Bojan Jelaković
Journal:  Croat Med J       Date:  2005-02       Impact factor: 1.351

Review 3.  Physiological evaluation of the isolated perfused rat kidney.

Authors:  T Maack
Journal:  Am J Physiol       Date:  1980-02

4.  Identification of a reduction product of aristolochic acid: implications for the metabolic activation of carcinogenic aristolochic acid.

Authors:  Horacio A Priestap; Carlos de los Santos; J Martin E Quirke
Journal:  J Nat Prod       Date:  2010-12-08       Impact factor: 4.050

5.  Study of the phase I and phase II metabolism of nephrotoxin aristolochic acid by liquid chromatography/tandem mass spectrometry.

Authors:  Wan Chan; Liang Cui; Guowang Xu; Zongwei Cai
Journal:  Rapid Commun Mass Spectrom       Date:  2006       Impact factor: 2.419

6.  Studies on the metabolism of aristolochic acids I and II.

Authors:  G Krumbiegel; J Hallensleben; W H Mennicke; N Rittmann; H J Roth
Journal:  Xenobiotica       Date:  1987-08       Impact factor: 1.908

7.  Characterization of pentamidine excretion in the isolated perfused rat kidney.

Authors:  Nagaraju R Poola; Michelle Kalis; Fotios M Plakogiannis; David R Taft
Journal:  J Antimicrob Chemother       Date:  2003-07-29       Impact factor: 5.790

8.  Hepatic cytochrome P450s metabolize aristolochic acid and reduce its kidney toxicity.

Authors:  Y Xiao; M Ge; X Xue; C Wang; H Wang; X Wu; L Li; L Liu; X Qi; Y Zhang; Y Li; H Luo; T Xie; J Gu; J Ren
Journal:  Kidney Int       Date:  2008-03-26       Impact factor: 10.612

9.  Role of mitochondrial permeability transition in human renal tubular epithelial cell death induced by aristolochic acid.

Authors:  Xinming Qi; Yan Cai; Likun Gong; Linlin Liu; Fangping Chen; Ying Xiao; Xiongfei Wu; Yan Li; Xiang Xue; Jin Ren
Journal:  Toxicol Appl Pharmacol       Date:  2007-04-12       Impact factor: 4.219

10.  Detection of DNA adducts formed by aristolochic acid in renal tissue from patients with Chinese herbs nephropathy.

Authors:  H H Schmeiser; C A Bieler; M Wiessler; C van Ypersele de Strihou; J P Cosyns
Journal:  Cancer Res       Date:  1996-05-01       Impact factor: 12.701

View more
  5 in total

1.  Human liver-kidney model elucidates the mechanisms of aristolochic acid nephrotoxicity.

Authors:  Shih-Yu Chang; Elijah J Weber; Viktoriya S Sidorenko; Alenka Chapron; Catherine K Yeung; Chunying Gao; Qingcheng Mao; Danny Shen; Joanne Wang; Thomas A Rosenquist; Kathleen G Dickman; Thomas Neumann; Arthur P Grollman; Edward J Kelly; Jonathan Himmelfarb; David L Eaton
Journal:  JCI Insight       Date:  2017-11-16

2.  A fluorescence-based analysis of aristolochic acid-derived DNA adducts.

Authors:  Victor Romanov; Victoria Sidorenko; Thomas A Rosenquist; Terry Whyard; Arthur P Grollman
Journal:  Anal Biochem       Date:  2012-04-04       Impact factor: 3.365

3.  Organomatics and organometrics: Novel platforms for long-term whole-organ culture.

Authors:  Bote G Bruinsma; Martin L Yarmush; Korkut Uygun
Journal:  Technology (Singap World Sci)       Date:  2014-03

4.  Mitochondrial Iron Overload-Mediated Inhibition of Nrf2-HO-1/GPX4 Assisted ALI-Induced Nephrotoxicity.

Authors:  Hui-Fang Deng; Lan-Xin Yue; Ning-Ning Wang; Yong-Qiang Zhou; Wei Zhou; Xian Liu; Yu-Hao Ni; Cong-Shu Huang; Li-Zhen Qiu; Hong Liu; Hong-Ling Tan; Xiang-Lin Tang; Yu-Guang Wang; Zeng-Chun Ma; Yue Gao
Journal:  Front Pharmacol       Date:  2021-01-21       Impact factor: 5.810

5.  Bioactivation of the human carcinogen aristolochic acid.

Authors:  Viktoriya S Sidorenko; Sivaprasad Attaluri; Irina Zaitseva; Charles R Iden; Kathleen G Dickman; Francis Johnson; Arthur P Grollman
Journal:  Carcinogenesis       Date:  2014-04-17       Impact factor: 4.944

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.